In a recent FDA inspection, investigators noted that airflow visualization studies used to qualify the aseptic processing environment were not performed under dynamic conditions. As a result, the studies were deemed insufficient to determine whether airflow was truly unidirectional during routine operations.
Static demonstrations of airflow may confirm theoretical design intent, but they do not necessarily reflect how air behaves when equipment is operating, components are present, or routine interventions occur.
The inspection narrative further describes localized turbulence observed near critical equipment surfaces during review of a specific airflow visualization study. Rather than showing smooth, unidirectional flow, smoke behavior indicated disrupted patterns in areas that would reasonably be expected to remain under the highest level of environmental control. These findings suggest that even within a classified area, airflow behavior may vary significantly at the micro-level, particularly around equipment geometries.
The FDA investigator criticized the methodology of the smoke study itself and noted that the smoke probe was not positioned at an angle sufficient to fully visualize airflow patterns around certain equipment features.
Finally, the observation notes that smoke was seen moving upward within the aseptic processing area and flowing into an adjacent ISO 7 space. This upward movement and the apparent pathway between classified areas raises questions about pressure differentials and the robustness of the air handling design as configured and operated at the time of the study.
This observation reflects FDA’s broader expectation that airflow visualization studies must be both representative and revealing. It is not enough to demonstrate that HEPA-filtered air is supplied under positive pressure in principle. The agency appears focused on whether studies are capable of detecting turbulence, reversals, or unintended airflow paths that could compromise aseptic conditions during real-world operations.
For quality teams, the takeaway is not about any single deficiency, but about the cumulative weight of study design and execution. As FDA continues to evaluate aseptic controls with increasing granularity, airflow visualization studies are being assessed as evidence of sustained environmental control under conditions that matter most.
Schedule a call to discuss joining GMP Trends
The referenced 483 is copied here:
…..Aseptic processing areas are deficient regarding air supply that is filtered through high-efficiency particulate air filters under positive pressure.
Specifically, the airflow visualization studies used to qualify the … with … were insufficient in that the airflows studies were not performed under dynamic conditions to determine unidirectionality of the airflow. In addition, during my review of your airflow visualization study for … Equipment ID …, it was observed that turbulent air near the … Lastly, the smoke probe was not positioned at an angle to fully visualize and access the airflow around the … in these … The smoke was observed to move in an upward direction within … and flow into the ISO 7 area.
